☆ 4.5 Letter

Adrenaline auto-injector prescription for patients at risk of anaphylaxis: BSACI guidance for primary care

CLINICAL AND EXPERIMENTAL ALLERGY (2023)

EAACI guideline: Anaphylaxis (2021 update)

Antonella Muraro et al.

Summary: The updated guideline on anaphylaxis emphasizes early recognition and prompt use of intramuscular adrenaline as first-line management. It also recommends comprehensive training for people at risk of anaphylaxis and improving healthcare professionals' management skills. Additionally, the urgent need for clinical trials to improve patient management in anaphylaxis is highlighted.

ALLERGY (2022)

添加到收藏夹

Article Allergy